New technologies are needed to keep up with the pace of change within the healthcare environment. The molecular diagnostics market is striving to develop solutions that are faster, more accurate, more accessible and flexible in use.
Novodiag® is an innovative molecular diagnostics solution allowing fully automated detection of infectious diseases, including antibiotic resistances. Combining qPCR and microarray technologies, Novodiag® allows direct analysis of a patient sample placed in a disposable cartridge for comprehensive screening of multiple or single pathogens within approximately 1 hour, versus a few days with current culture methods. Thanks to this unique and fl exible solution, clinicians can ensure patient care and safety requiring time-critical decisions in order to deliver early treatments and avoid infection spreading.